Stockscreener 앱 받기
20.65
4.22%
-0.91
시간 외 거래:
20.81
0.16
+0.77%
전일 마감가:
$21.56
열려 있는:
$21
하루 거래량:
17,519
Relative Volume:
0.64
시가총액:
$222.33M
수익:
$75.03M
순이익/손실:
$-7.71M
주가수익비율:
-28.62
EPS:
-0.7214
순현금흐름:
$-3.95M
1주 성능:
+3.82%
1개월 성능:
+8.00%
6개월 성능:
+103.45%
1년 성능:
+618.26%
1일 변동 폭
$20.50
$21.22
1주일 범위
$19.12
$22.50
52주 변동 폭
$2.18
$41.72
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Compare BNR vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
20.65 | 232.13M | 75.03M | -7.71M | -3.95M | -0.7214 |
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2020-07-07 | 개시 | Cowen | Outperform |
Burning Rock Biotech Ltd Adr 주식(BNR)의 최신 뉴스
Cancer screening company Faces Tough IPO Test As Market Cools - Benzinga
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer By Investing.com - Investing.com South Africa
Aurelion Inc. appoints Yuki Xu as acting chief accounting officer - Investing.com
Burning Rock Biotech (NASDAQ:BNR) Director Purchases $5,466,143.20 in Stock - MarketBeat
Burning Rock CEO purchases $546,604 in company shares - Investing.com
Burning Rock CEO purchases $546,604 in company shares By Investing.com - Investing.com India
Burning Rock Biotech (BNR) Expected to Announce Earnings on Tuesday - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Stock Price Down 9.8%Here's What Happened - MarketBeat
(BNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Burning Rock Biotech (BNR) Stock Price, News & Analysis $BNR - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Trading Down 9.7%Here's What Happened - MarketBeat
Intel and AMD among market cap stock movers on Friday By Investing.com - Investing.com Australia
Intel, Iris Energy among market cap stock movers on Friday By Investing.com - Investing.com Nigeria
Intel, Iris Energy among market cap stock movers on Friday - Investing.com
Intel and AMD among market cap stock movers on Friday - Investing.com
Alibaba and Facebook among market cap stock movers on Thursday - Investing.com
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Update - MarketBeat
Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) Short Interest Up 34.3% in December - MarketBeat
Burning Rock Announces Results of 2025 Annual General Meeting - ChartMill
Burning Rock Biotech (NASDAQ:BNR) Trading 0.1% HigherWhat's Next? - MarketBeat
Operating margin % of Burning Rock Biotech Ltd. Sponsored ADR – LSX:A40AE6 - TradingView
A40AE6 Stock Price and Chart — LSX:A40AE6 - TradingView
Operating margin % of Burning Rock Biotech Ltd. Sponsored ADR – LS:A40AE6 - TradingView
Burning Rock Stock Up 35%+ As Loss Narrows - Sahm
Wall Street analysts’ outlook for Acumen Pharmaceuticals Inc (ABOS) - setenews.com
Metals News and Commentary - Barchart.com
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Barchart.com
Empowering Investor Success - Morningstar
BNR: Pharma R&D growth and cost controls drove higher margins and a reduced net loss in Q3 2025 - TradingView
BNR: 3Q25 saw positive cash flow, higher margins, and strong pharma R&D and overseas revenue growth - TradingView
Operating cash flow per share of Burning Rock Biotech Ltd. Sponsored ADR – SWB:6BU0 - TradingView
Its Stock Has Paid Off Big Time For Atlas Lithium Corporation - Setenews
Its Stock Has Paid Off Big Time For Strategy Inc - Setenews
It is Poised to be a Bull Market for HCM II Acquisition Corp (HOND) - Setenews
Burning Rock Biotech (NASDAQ:BNR) Trading 2.8% Higher – Time to Buy? - Defense World
Burning Rock Biotech (NASDAQ:BNR) Trading 2.8% HigherTime to Buy? - MarketBeat
Burning Rock Biotech (NASDAQ:BNR) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
HSG HOLDING LTD Institutional Portfolio - Nasdaq
A significant driver of top-line growth: Neonode Inc (NEON) - Setenews
Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Finviz
KindlyMD (NAKA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
UK Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Dividend News and Commentary - Barchart.com
The United States Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China - ChartMill
Saudi Arabia Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech Ltd Share Price ADR Each Representing 10 Ord A Shares SPON - Hargreaves Lansdown
symbol__ Stock Quote Price and Forecast - CNN
Recent Insider BuyingStock ScreenerSnapshot - Finviz
What is the current Price Target and Forecast for Burning Rock Biotech (BNR) - Zacks Investment Research
Profitably Trade Stocks at 52-Week Highs - MarketBeat
Burning Rock Biotech Ltd Adr (BNR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.57%
0.03%
자본화:
|
볼륨(24시간):